Singh, C. et al. 2022. High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. Acta Oncologica. 61, 12 (Dec. 2022), 1512–1514. DOI:https://doi.org/10.1080/0284186X.2022.2162347.